Ignite Creation Date:
2025-12-24 @ 2:49 PM
Ignite Modification Date:
2026-03-12 @ 10:43 AM
Study NCT ID:
NCT02201459
Status:
COMPLETED
Last Update Posted:
2025-10-02
First Post:
2014-06-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients
Sponsor:
Hospices Civils de Lyon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08
Start Date Type:
None
Primary Completion Date:
2022-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-06-24
First Submit QC Date:
None
Study First Post Date:
2014-07-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-27
Last Update Post Date:
2025-10-02
Last Update Post Date Type:
ESTIMATED